Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
OPM Seeks Medical Records of 8 Million Federal Workers, Sparking Privacy Outcry
The Office of Personnel Management (OPM) has issued a rule requiring insurers that cover federal employees and retirees to submit detailed, identifiable medical and pharmacy claims for roughly 8 million people. Critics say the move threatens privacy, could enable political targeting, and lacks clear safeguards.
How Expiring ACA Enhanced Premium Tax Credits Hurt Business
The expiration of the ACA’s enhanced premium tax credits has forced self‑employed entrepreneurs to see their monthly health‑insurance costs jump from zero to $2,300, dramatically tightening household budgets. In 2025, more than 4.4 million of the 5.2 million small‑business owners who relied...
Exploring the Value of Quality Peptide Supplies
Peptide research has surged, making high‑purity synthetic peptides essential for reliable experiments. Quality hinges on ≥98% purity verified by HPLC, accurate molecular weight confirmed by mass spectrometry, and proper lyophilization with cold‑chain logistics. The article outlines a supplier checklist—third‑party testing,...
Chinese Researchers Demonstrate CRISPR Cure for Β‑Thalassaemia in Clinical Trial
A consortium of Chinese scientists has shown that an enhanced CRISPR/Cas9 platform can safely correct the genetic defect behind β‑Thalassaemia in patients. The study builds on the recent FDA approval of a CRISPR therapy for sickle‑cell anemia and suggests a...
Lessons From HIMSS: AI Will Not Fix Healthcare: Informed Leadership Might
At HIMSS 2026, industry leaders acknowledged that AI is no longer a future possibility but a present reality in healthcare, with over 1,200 AI‑enabled medical devices already in use in the United States. However, the rapid pace of adoption has...
Bial Launches Education and Awareness Campaign for World Parkinson’s Day
Bial, the Portuguese biopharma focused on neuroscience, has launched “Dialogues with Parkinson’s,” a year‑long education campaign in partnership with Parkinson’s Europe. The initiative aims to improve communication among patients, caregivers and clinicians to promote earlier diagnosis, especially for the 10‑20%...
Senju Launches First-in-Class Dry Eye Disease Drug in Japan
Senju Pharma has launched Avarept, the first TRPV1 antagonist drug for dry eye disease (DED) in Japan, licensed from Mochida and distributed by Takeda. The ophthalmic suspension is priced at ¥577.50 (approximately $3.63) per 5 ml bottle. DED affects over 20 million...
NVIDIA Just Helped Map 31 Million Protein Complexes and the Health Tech Investment Implications Are Enormous
NVIDIA, DeepMind, EMBL‑EBI and Seoul National University expanded the AlphaFold Protein Structure Database to include 31 million predicted protein complexes—23.4 million homodimers and 7.6 million heterodimers—across 4,777 proteomes. Using H100 DGX Superpod clusters, MMseqs2‑GPU and TensorRT‑accelerated inference, the team generated 1.8 million high‑confidence homodimer...
Pharmaceutical Tariffs and the Restructuring of Global Drug Supply Chains
The United States is rolling out new tariffs on imported pharmaceutical products, affecting an estimated $200‑$250 billion in annual trade. Because 70‑80% of active pharmaceutical ingredient (API) production is concentrated in India and China, manufacturers face limited flexibility and longer lead...
From Unused Data to Improved Experiences - How Trillium Health Partners Put Patient Voices to Work with Qualtrics
Trillium Health Partners in Mississauga replaced paper‑based patient surveys with Qualtrics’ digital platform, enabling feedback delivery within 24 hours of discharge. The real‑time insight allows unit managers to see complaints and compliments within days, turning stale data into actionable improvement. By...
Oxford BioTherapeutics Partners with BMS to Develop Next-Generation T-Cell Engagers for Solid Tumors
Oxford BioTherapeutics (OBT) announced a multi‑year strategic collaboration with Bristol Myers Squibb (BMS) to discover and develop next‑generation T‑cell engager therapies for solid tumors. OBT will apply its OGAP‑Verify platform to identify tumor‑selective antigens and design candidate molecules, while BMS...
The Healthcare Burnout Backlash (Pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
The third installment of MedTech Intelligence’s burnout series argues that staffing shortages are symptoms of outdated, siloed workflows rather than pure labor deficits. Healthcare leaders are turning to targeted workflow redesign—especially in patient access, revenue cycle and EHR processes—to eliminate...
BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
BD announced that its Liverty TIPS Stent Graft has received CE Mark approval, allowing sales across the European Union. The next‑generation device features an adjustable 6–10 mm inner diameter and the longest range of covered TIPS stent lengths, aimed at personalizing...
Oricell Therapeutics Raises $110 Million to Advance Global Cell Therapy Development
Oricell Therapeutics announced a $110 million pre‑IPO financing round aimed at accelerating its global cell‑therapy program. The capital will fund expanded clinical trials, manufacturing upgrades, and a broader market rollout, especially for its lead liver‑cancer therapy that is nearing pivotal studies....
From Arsenic in Antifreeze to a Single Pill
Human African trypanosomiasis, or sleeping sickness, once required melarsoprol—an arsenic‑based injection that killed the parasite but caused severe brain reactions and a 5% mortality rate. In 2024 the European Medicines Agency approved acoziborole, a single‑dose oral therapy with a 96%...
NMN Daily Restores NAD, Supports Healthy Aging
David Sinclair takes 1 gram of NMN every single day. Here's why. As you age, your body loses up to 50% of a molecule called NAD. NAD is a molecule that acts like fuel powering your sirtuin genes - the genes responsible...
Young Mitochondria Transplants Could Reverse Aging and Disease
What if aging, ALS, Parkinson's, stroke, and diabetes all share a single upstream cause — and the fix is a transplant the size of a bacterium? Dr. Catherine Baucom and Van Hipp of MitoSense explain how injecting healthy young mitochondria...
Endospan Receives FDA Approval for the NEXUS Aortic Arch Stent Graft System
Endospan announced FDA approval of its NEXUS Aortic Arch Stent Graft System, clearing the way for a U.S. commercial launch. The clearance was based on one‑year results from the TRIOMPHE IDE study, which demonstrated safe and effective treatment of high‑risk...
The Deadly Labyrinth of Nigerian Healthcare
Gazelle Mba’s personal narrative reveals chronic failures in Nigeria’s health system, from absent ambulances and ID‑driven triage to under‑trained staff performing risky procedures. Her mother survived a bus crash and a botched kidney‑stone surgery that caused a total spinal block,...
Scientists Uncover the Neurological Mechanisms Behind Cannabis-Induced “Munchies”
A University of Calgary team published a study in PNAS showing that inhaled THC vapor triggers a robust, short‑lived increase in food consumption in both humans and rats. In a controlled trial with 82 volunteers, any dose of cannabis vapor...
Apr 10 Policy Watch: HHS Updates Criteria for Selecting Vaccine-Committee Members
The U.S. Health and Human Services Department renewed the Advisory Committee on Immunization Practices charter, shifting from professional‑society representation to a broader, geographically and specialty‑balanced membership. The EPA finalized a rule extending permissible natural‑gas flaring to 72 hours and easing...
Slidell Doctor Sentenced For $6.6 Million In Health Care Fraud
Robert Tassin, a 67‑year‑old physician from Slidell, Louisiana, was sentenced on April 9, 2026 for conspiring to commit healthcare fraud by ordering medically unnecessary cancer genetic tests for Medicare patients he never saw. The scheme generated over $6.6 million in false claims, of...
NIH Awards Fewer Grants Despite Increased Funding, Raising Concerns over Research Delays
Despite a recent federal funding boost, the National Institutes of Health has awarded only about 30% of the new research grants it typically funds this fiscal year. Delays in fund disbursement, driven by Office of Management and Budget restrictions, have...
Will RFK Jr.’s Peptide Push Bolster the Gray Market for Obesity Drugs?
Robert F. Kennedy Jr. is urging the FDA to reclassify more than a dozen synthetic peptides from the restricted Category 2 list to Category 1, allowing compounding by licensed pharmacies with a prescription. The move follows a high‑profile appearance on the Joe...
Biotech’s IPO Comeback; Trump’s Tariff Loophole for Pharma
Biotech IPO activity is resurging, highlighted by Evommune’s public listing and a panel at the BIO International Convention discussing renewed exit opportunities. AI-driven collaborations, such as Insilico Medicine and Aska Pharmaceutical, aim to tackle unmet needs in women’s health by...
Re: Make Compassion Visible in Emergency Medicine Again
In a response to Iain Beardsell’s article, emergency‑medicine consultant Chris Turner argues that the profession’s growing systemic strain has dulled compassion, turning clinicians into inadvertent partners in a failing system. He cites moral injury from the shift between risk mitigation...
Orthanc DICOM Vulnerabilities Lead to Crashes, RCE
A CERT/CC advisory disclosed nine critical vulnerabilities (CVE‑2026‑5437 to CVE‑2026‑5445) in the open‑source Orthanc DICOM server, affecting versions up to 1.12.10. The flaws include out‑of‑bounds reads, decompression‑bombs, memory‑exhaustion bugs, and heap buffer overflows that can crash servers, leak image data,...
InVera Medical Receives FDA Clearance for Non-Thermal Chronic Venous Disease Device
InVera Medical secured FDA 510(k) clearance for its InVera Infusion Device, a 5Fr catheter with a helical coil designed to improve sclerotherapy delivery for chronic venous disease (CVD). The non‑thermal, minimally invasive tool prepares the vein wall mechanically, allowing a...
Secretary Kennedy Takes Health Tour to Arizona Indian Country
Secretary of Health and Human Services Robert F. Kennedy Jr. delivered a keynote and fireside chat at the Tribal Self‑Governance Conference in Chandler, Arizona, spotlighting the alarming rise in diabetes among the Pima Tribe. He announced a $1 billion infrastructure allocation...
Diagnostics Lag Is Holding Back New Therapies, Says Study
A new UCSF analysis published in Science warns that diagnostic development is lagging behind therapeutic breakthroughs because of regulatory and reimbursement gaps. The authors highlight that nearly half of the world’s population—about 47%—has limited or no access to essential tests,...
Blocking 15-PGDH Reverses Age‑Related Cartilage Loss
As a medical school professor, I was taught that lost cartilage is gone forever. Stanford just proved that wrong. Researchers discovered that blocking a single protein (15-PGDH) -- which rises as we age -- can actually REGROW joint cartilage in aging mice. The...
Veeva V. Epic: Kicking the Can in Dane County
Veeva filed a robust opposition to Epic Systems’ motion to dismiss, targeting the enforceability of Epic’s equity clawback, non‑compete provisions, and arbitration clauses. The response leaned heavily on a Wisconsin "in terrorem" theory, arguing that the clawback itself deters competition...
Weekly Neuroscience Update
A wave of neuroscience research highlights non‑drug therapies and genetic insights that could reshape treatment for mental health, cancer‑related cognitive issues, and metabolic disorders. Transcranial magnetic stimulation shows lasting reduction of PTSD fear responses, while electroacupuncture improves cognition and alleviates...
Senkyunolides: A Promising Natural Compounds for the Treatment of Migraine Headaches
A Frontiers in Nutrition review published April 10, 2026 examines senkyunolides—phthalide‑type compounds from herbs such as Ligusticum chuanxiong—as a new class of natural anti‑migraine agents. The authors detail the compounds’ chemical diversity, modern extraction and purification methods, and multi‑target mechanisms that modulate...
The Preoperative Albumin-to-Carcinoembryonic Antigen Ratio (ACR) Predicts Prognosis and Facilitates Risk Stratification in Gastric Cancer: A Retrospective Cohort Study
The retrospective cohort of 1,161 gastric‑cancer patients who underwent radical gastrectomy showed that a low pre‑operative albumin‑to‑CEA ratio (ACR) correlates with aggressive pathology and significantly shorter overall and disease‑free survival. Multivariate Cox analysis identified high ACR as an independent protective...
The Effect of Immunonutrition on Postoperative Ileus Following Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
A systematic review and meta‑analysis of 28 randomized trials involving 2,367 colorectal cancer patients found that peri‑operative immunonutrition significantly accelerates gastrointestinal recovery. Compared with standard diet, immunonutrition reduced time to first flatus by 0.56 days, time to first defecation by...
DualityBio Reports China NMPA Acceptance of BLA for Trastuzumab Pamirtecan in Metastatic HER2+ Breast Cancer
DualityBio announced that China’s National Medical Products Administration has accepted its Biologics License Application for trastuzumab pamirtecan (T‑Pam), an investigational antibody‑drug conjugate targeting HER2‑positive metastatic breast cancer. The submission is backed by interim data from the pivotal Phase III DB‑1303‑O‑3001 trial,...
A NICE-Approved Treatment for 8 Million People that Fewer than 0.5% of Clinicians Offer
A new health‑tech model is delivering a NICE‑approved therapy to roughly 8 million UK patients who currently lack access, as fewer than 0.5% of clinicians prescribe it. The approach bypasses traditional hospital pathways, offering direct‑to‑consumer (DTC) prescribing and remote monitoring. Early...
FDA Probes Abortion Pill Anew After Court Keeps Mail Access Alive
The FDA announced a renewed, accelerated safety study of the abortion pill mifepristone, aiming to complete the review faster than typical academic timelines. The move follows a Louisiana federal judge’s decision to temporarily allow the drug’s distribution by mail while...
New GLP‑3 Drug Reta May Target Fat, Spark Hunger
Like it or not, GLP-1-based weight loss drugs are here to stay. 1/2) What's more, people are experimenting with newer evolutions, like "reta" (retatrutide/GLP-3). As an MD PhD & metabolism scientist, I decided to start my own experiment to help answer...
The Hidden Clinical Cost of HCC Coding in Primary Care
Hierarchical condition category (HCC) coding, intended for Medicare Advantage risk adjustment, now interrupts primary‑care visits with electronic alerts demanding physicians verify dozens of diagnoses. The workflow intrusion adds significant time to typical 15‑minute appointments, pulling clinicians away from patient interaction...
Novo's Double Departures: As GLP-1 Luminary Retires, an Obesity Leader Goes to Boehringer Ingelheim
Novo Nordisk announced two high‑profile departures this week. Lotte Bjerre Knudsen, a veteran who helped launch the company’s breakthrough GLP‑1 therapies, is retiring after more than two decades. At the same time, the head of Novo’s obesity unit has accepted a...
Ind. FD Launches Program to Divert Non-Emergency 911 Calls to Nurses
The Terre Haute Fire Department (THFD) has launched the Crosswalk to Care program to divert low‑acuity 911 calls to registered nurses for appropriate care navigation. Over the past seven years, THFD’s run calls grew by 450 annually, with roughly 20%—about...
Chinese Trial Backs Base-Editing Drug for Thalassaemia
A Chinese investigator‑led trial of CorrectSequence Therapeutics' ex vivo base‑editing drug CS‑101 showed that all five patients with transfusion‑dependent beta‑thalassaemia became transfusion‑independent after a single infusion, with an average cessation time of 16 days and sustained hemoglobin gains over three months....
Meth Patients Face Dental Crisis Amid Medicaid Gaps
You check the heart, the lungs, the skin, the reflexes. Then you skip the mouth entirely. A dentist at a safety-net clinic in Massachusetts treated a patient who had been on methamphetamine for seven years. Every tooth decayed. Gums bleeding...
Sobi Reports Health Canada Approval of Empaveli for C3G and Primary IC-MPGN
Health Canada has granted approval for Empaveli (pegcetacoplan) to treat patients aged 12 and older with C3 glomerulopathy (C3G) or primary immune‑complex membranoproliferative glomerulonephritis (IC‑MPGN). The decision follows the Phase III VALIANT trial, which demonstrated a 68% reduction in proteinuria, stabilization...
WHO Unveils Global Curriculum Guide for Community Health Workers
The World Health Organization today launched a Global Curriculum Guide for Community Health Workers and a step‑by‑step integration manual. The resources are intended to standardize training, strengthen primary health care systems and help ministries of health scale community health worker...
X‑rays Mislead Knee Osteoarthritis Treatment Decisions
Osteoarthritis Of The Knee... Thread #1... of 4 "Bone on bone." "Your cartilage is worn away." "You have the knee of a 90 year old." I've heard these phrases bantered about thousands of times in 25 years. They are very common...
America’s Healthcare Innovation Problem
The article argues that U.S. healthcare innovation suffers from a culture that declares success too early and hides failure, using examples from Medicare Advantage and the Theranos scandal. It highlights how funding, valuations, and hype often replace rigorous outcome evaluation,...
Meal Delivery and Phone Counseling Cut Veteran Blood Pressure in New Trial
A randomized trial led by University of Michigan and VA Ann Arbor found that two weeks of home‑delivered DASH‑SRD meals followed by five phone‑based dietitian sessions reduced blood pressure in middle‑aged and older veterans with hypertension and obesity. The study,...